Tag Archive for revenue 2025

Zinzino Revenue Q1 Up 59% To $74.69 Million

Zinzino AB  Interim Report First Quarter 2025
Based on SEK 100 = $USD 10.33 (Business For Home editor)

Revenues in the first quarter of 2025 amounted to SEK 723.7 (454.5) million, corresponding to 59% (15%) growth compared to the corresponding period last year.

In local currencies, revenues for the first quarter increased by 60% compared to the corresponding period last year. EBITDA increased to SEK 78.8 (51.7) million and the EBITDA margin amounted to 10.9% (11.4%). During the quarter, the acquisition of Zurvita’s assets with associated distributor and customer database was completed.
The acquisition consolidates Zinzino’s position in North America and adds further growth in the region. In addition, New Zealand was launched as an official market during the quarter. After the end of the quarter, the assets of the US/UK based direct sales company Valentus Global was acquired in order to add increased distribution power in Europe.
January – March 2025

Total revenue amounted to SEK 723.7 (454.5) million, corresponding to a growth of 59% (15%)
Gross profit amounted to SEK 223.6 (160.9) million and the gross profit margin was 30.9% (35.4%)
EBITDA amounted to SEK 78.8 (51.7) million and the EBITDA margin was 10.9% (11.4%)
Cash flow from operating activities totalled SEK 21.1 (-1.7) million
Zinzino’s Board

Read more...

LifeVantage Revenue Q1 2025 Up 21.1% To $58.4 Million

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025.
Third Quarter Fiscal 2025 Summary*:

Revenue was $58.4 million, an increase of 21.1% from the prior year period.
Excluding the negative impact of foreign currency fluctuations, third quarter revenue increased approximately 22.1%;
Revenue in the Americas increased 29.5%, and revenue in Asia/Pacific & Europe decreased 7.2%.
Excluding the negative impact of foreign currency fluctuations, third quarter revenue in Asia/Pacific & Europe decreased approximately 4.7%;
Net income per diluted share was $0.26, versus $0.13 per diluted share a year ago;
Adjusted earnings per diluted share was $0.26, compared to $0.21 a year ago; and
Adjusted EBITDA was $6.4 million compared to $5.1 million a year ago.

* All comparisons are on a year over year basis and compare the third quarter of fiscal 2025 to the third quarter of fiscal 2024, unless otherwise noted.
Steve Fife, President and CEO of LifeVantage said:

“Third quarter results were strong with revenues up 21% year-over-year to $58.4 million, reflecting robust demand for our MindBody GLP-1 System™. We also delivered another quarter of improving profitability including a 210 basis point improvement

Read more...